nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—AKR1C1—uterine cancer	0.365	0.658	CbGaD
Acetylsalicylic acid—TP53—uterine cancer	0.19	0.342	CbGaD
Acetylsalicylic acid—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0342	0.168	CbGbCtD
Acetylsalicylic acid—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0239	0.117	CbGbCtD
Acetylsalicylic acid—CYP2C8—Progesterone—uterine cancer	0.0227	0.112	CbGbCtD
Acetylsalicylic acid—PTGS2—Etoposide—uterine cancer	0.0208	0.102	CbGbCtD
Acetylsalicylic acid—CYP2C19—Progesterone—uterine cancer	0.019	0.0936	CbGbCtD
Acetylsalicylic acid—PTGS1—Etoposide—uterine cancer	0.0176	0.0865	CbGbCtD
Acetylsalicylic acid—CYP2C9—Progesterone—uterine cancer	0.0158	0.0778	CbGbCtD
Acetylsalicylic acid—ABCB1—Progesterone—uterine cancer	0.0154	0.0755	CbGbCtD
Acetylsalicylic acid—ABCB1—Dactinomycin—uterine cancer	0.0122	0.0599	CbGbCtD
Acetylsalicylic acid—CYP2C8—Etoposide—uterine cancer	0.0102	0.0499	CbGbCtD
Acetylsalicylic acid—ABCB1—Etoposide—uterine cancer	0.00687	0.0338	CbGbCtD
Acetylsalicylic acid—ABCB1—Doxorubicin—uterine cancer	0.00469	0.023	CbGbCtD
Acetylsalicylic acid—TP53—oviduct—uterine cancer	0.00394	0.0535	CbGeAlD
Acetylsalicylic acid—HSPA5—oviduct—uterine cancer	0.0038	0.0515	CbGeAlD
Acetylsalicylic acid—Haemorrhagic disorder—Medroxyprogesterone Acetate—uterine cancer	0.00264	0.0435	CcSEcCtD
Acetylsalicylic acid—TP53—exocrine gland—uterine cancer	0.00228	0.0309	CbGeAlD
Acetylsalicylic acid—NFKBIA—exocrine gland—uterine cancer	0.00224	0.0304	CbGeAlD
Acetylsalicylic acid—HSPA5—exocrine gland—uterine cancer	0.00219	0.0297	CbGeAlD
Acetylsalicylic acid—Clotting—Progesterone—uterine cancer	0.00206	0.034	CcSEcCtD
Acetylsalicylic acid—Breast feeding—Medroxyprogesterone Acetate—uterine cancer	0.00191	0.0315	CcSEcCtD
Acetylsalicylic acid—Clotting—Medroxyprogesterone Acetate—uterine cancer	0.00186	0.0308	CcSEcCtD
Acetylsalicylic acid—Foetor hepaticus—Progesterone—uterine cancer	0.0013	0.0214	CcSEcCtD
Acetylsalicylic acid—TP53—myometrium—uterine cancer	0.00126	0.0171	CbGeAlD
Acetylsalicylic acid—Mefenamic acid—AKR1C1—uterine cancer	0.00125	0.32	CrCbGaD
Acetylsalicylic acid—NFKBIA—myometrium—uterine cancer	0.00124	0.0168	CbGeAlD
Acetylsalicylic acid—HSPA5—myometrium—uterine cancer	0.00122	0.0165	CbGeAlD
Acetylsalicylic acid—Foetor hepaticus—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.0194	CcSEcCtD
Acetylsalicylic acid—Liver disorder—Progesterone—uterine cancer	0.00108	0.0178	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—myometrium—uterine cancer	0.00104	0.014	CbGeAlD
Acetylsalicylic acid—Salicylic acid—AKR1C1—uterine cancer	0.001	0.256	CrCbGaD
Acetylsalicylic acid—TP53—epithelium—uterine cancer	0.00099	0.0134	CbGeAlD
Acetylsalicylic acid—TP53—uterine cervix—uterine cancer	0.000982	0.0133	CbGeAlD
Acetylsalicylic acid—Liver disorder—Medroxyprogesterone Acetate—uterine cancer	0.000977	0.0161	CcSEcCtD
Acetylsalicylic acid—NFKBIA—epithelium—uterine cancer	0.000974	0.0132	CbGeAlD
Acetylsalicylic acid—Heartburn—Medroxyprogesterone Acetate—uterine cancer	0.000968	0.016	CcSEcCtD
Acetylsalicylic acid—NFKBIA—uterine cervix—uterine cancer	0.000966	0.0131	CbGeAlD
Acetylsalicylic acid—HSPA5—epithelium—uterine cancer	0.000954	0.0129	CbGeAlD
Acetylsalicylic acid—TP53—smooth muscle tissue—uterine cancer	0.000954	0.0129	CbGeAlD
Acetylsalicylic acid—Metabolic acidosis—Etoposide—uterine cancer	0.000951	0.0157	CcSEcCtD
Acetylsalicylic acid—HSPA5—uterine cervix—uterine cancer	0.000946	0.0128	CbGeAlD
Acetylsalicylic acid—Coagulopathy—Progesterone—uterine cancer	0.000944	0.0156	CcSEcCtD
Acetylsalicylic acid—NFKBIA—smooth muscle tissue—uterine cancer	0.000939	0.0127	CbGeAlD
Acetylsalicylic acid—TP53—decidua—uterine cancer	0.000935	0.0127	CbGeAlD
Acetylsalicylic acid—Meclofenamic acid—AKR1C3—uterine cancer	0.000933	0.239	CrCbGaD
Acetylsalicylic acid—NFKBIA—decidua—uterine cancer	0.00092	0.0125	CbGeAlD
Acetylsalicylic acid—HSPA5—smooth muscle tissue—uterine cancer	0.000919	0.0125	CbGeAlD
Acetylsalicylic acid—TP53—renal system—uterine cancer	0.000918	0.0125	CbGeAlD
Acetylsalicylic acid—NFKBIA—renal system—uterine cancer	0.000904	0.0123	CbGeAlD
Acetylsalicylic acid—HSPA5—decidua—uterine cancer	0.000901	0.0122	CbGeAlD
Acetylsalicylic acid—TP53—endometrium—uterine cancer	0.000888	0.012	CbGeAlD
Acetylsalicylic acid—HSPA5—renal system—uterine cancer	0.000885	0.012	CbGeAlD
Acetylsalicylic acid—NFKBIA—endometrium—uterine cancer	0.000874	0.0118	CbGeAlD
Acetylsalicylic acid—TP53—mammalian vulva—uterine cancer	0.000859	0.0116	CbGeAlD
Acetylsalicylic acid—HSPA5—endometrium—uterine cancer	0.000856	0.0116	CbGeAlD
Acetylsalicylic acid—Coagulopathy—Medroxyprogesterone Acetate—uterine cancer	0.000855	0.0141	CcSEcCtD
Acetylsalicylic acid—NFKBIA—mammalian vulva—uterine cancer	0.000845	0.0115	CbGeAlD
Acetylsalicylic acid—Eruption—Dactinomycin—uterine cancer	0.000845	0.0139	CcSEcCtD
Acetylsalicylic acid—EDNRA—myometrium—uterine cancer	0.000842	0.0114	CbGeAlD
Acetylsalicylic acid—HSPA5—mammalian vulva—uterine cancer	0.000828	0.0112	CbGeAlD
Acetylsalicylic acid—TP53—uterus—uterine cancer	0.000818	0.0111	CbGeAlD
Acetylsalicylic acid—RPS6KA3—uterine cervix—uterine cancer	0.000806	0.0109	CbGeAlD
Acetylsalicylic acid—NFKBIA—uterus—uterine cancer	0.000805	0.0109	CbGeAlD
Acetylsalicylic acid—PTGS1—oviduct—uterine cancer	0.000795	0.0108	CbGeAlD
Acetylsalicylic acid—HSPA5—uterus—uterine cancer	0.000788	0.0107	CbGeAlD
Acetylsalicylic acid—RPS6KA3—decidua—uterine cancer	0.000768	0.0104	CbGeAlD
Acetylsalicylic acid—IKBKB—myometrium—uterine cancer	0.000764	0.0104	CbGeAlD
Acetylsalicylic acid—RPS6KA3—renal system—uterine cancer	0.000754	0.0102	CbGeAlD
Acetylsalicylic acid—TP53—female reproductive system—uterine cancer	0.000736	0.00997	CbGeAlD
Acetylsalicylic acid—Hepatocellular injury—Progesterone—uterine cancer	0.000735	0.0121	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—endometrium—uterine cancer	0.000729	0.00988	CbGeAlD
Acetylsalicylic acid—Mefenamic acid—AKR1C3—uterine cancer	0.000725	0.186	CrCbGaD
Acetylsalicylic acid—NFKBIA—female reproductive system—uterine cancer	0.000724	0.00981	CbGeAlD
Acetylsalicylic acid—HSPA5—female reproductive system—uterine cancer	0.000709	0.00961	CbGeAlD
Acetylsalicylic acid—RPS6KA3—mammalian vulva—uterine cancer	0.000705	0.00956	CbGeAlD
Acetylsalicylic acid—Ulcer—Medroxyprogesterone Acetate—uterine cancer	0.000704	0.0116	CcSEcCtD
Acetylsalicylic acid—Hepatotoxicity—Dactinomycin—uterine cancer	0.000673	0.0111	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—uterus—uterine cancer	0.000672	0.00911	CbGeAlD
Acetylsalicylic acid—TP53—female gonad—uterine cancer	0.000669	0.00908	CbGeAlD
Acetylsalicylic acid—Coagulopathy—Dactinomycin—uterine cancer	0.000667	0.011	CcSEcCtD
Acetylsalicylic acid—Hepatocellular injury—Medroxyprogesterone Acetate—uterine cancer	0.000666	0.011	CcSEcCtD
Acetylsalicylic acid—TP53—vagina—uterine cancer	0.000665	0.00902	CbGeAlD
Acetylsalicylic acid—NFKBIA—female gonad—uterine cancer	0.000658	0.00893	CbGeAlD
Acetylsalicylic acid—Lightheadedness—Progesterone—uterine cancer	0.000658	0.0109	CcSEcCtD
Acetylsalicylic acid—EDNRA—uterine cervix—uterine cancer	0.000655	0.00888	CbGeAlD
Acetylsalicylic acid—NFKBIA—vagina—uterine cancer	0.000655	0.00887	CbGeAlD
Acetylsalicylic acid—HSPA5—female gonad—uterine cancer	0.000645	0.00874	CbGeAlD
Acetylsalicylic acid—HSPA5—vagina—uterine cancer	0.000641	0.00869	CbGeAlD
Acetylsalicylic acid—EDNRA—decidua—uterine cancer	0.000624	0.00846	CbGeAlD
Acetylsalicylic acid—RPS6KA3—female reproductive system—uterine cancer	0.000604	0.00819	CbGeAlD
Acetylsalicylic acid—Vascular purpura—Progesterone—uterine cancer	0.000596	0.00985	CcSEcCtD
Acetylsalicylic acid—IKBKB—uterine cervix—uterine cancer	0.000595	0.00806	CbGeAlD
Acetylsalicylic acid—EDNRA—endometrium—uterine cancer	0.000592	0.00803	CbGeAlD
Acetylsalicylic acid—IKBKB—smooth muscle tissue—uterine cancer	0.000578	0.00784	CbGeAlD
Acetylsalicylic acid—EDNRA—mammalian vulva—uterine cancer	0.000573	0.00777	CbGeAlD
Acetylsalicylic acid—IKBKB—decidua—uterine cancer	0.000567	0.00768	CbGeAlD
Acetylsalicylic acid—Thirst—Progesterone—uterine cancer	0.000561	0.00926	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Medroxyprogesterone Acetate—uterine cancer	0.000556	0.00918	CcSEcCtD
Acetylsalicylic acid—Purpura—Progesterone—uterine cancer	0.000554	0.00914	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—female gonad—uterine cancer	0.000549	0.00745	CbGeAlD
Acetylsalicylic acid—Ulcer—Dactinomycin—uterine cancer	0.000549	0.00907	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—vagina—uterine cancer	0.000546	0.0074	CbGeAlD
Acetylsalicylic acid—EDNRA—uterus—uterine cancer	0.000546	0.0074	CbGeAlD
Acetylsalicylic acid—SLC22A7—renal system—uterine cancer	0.00054	0.00732	CbGeAlD
Acetylsalicylic acid—IKBKB—endometrium—uterine cancer	0.000538	0.00729	CbGeAlD
Acetylsalicylic acid—PTGS1—artery—uterine cancer	0.000526	0.00714	CbGeAlD
Acetylsalicylic acid—IKBKB—mammalian vulva—uterine cancer	0.00052	0.00706	CbGeAlD
Acetylsalicylic acid—Thirst—Medroxyprogesterone Acetate—uterine cancer	0.000508	0.00839	CcSEcCtD
Acetylsalicylic acid—PTGS2—artery—uterine cancer	0.000503	0.00682	CbGeAlD
Acetylsalicylic acid—Purpura—Medroxyprogesterone Acetate—uterine cancer	0.000502	0.00828	CcSEcCtD
Acetylsalicylic acid—IKBKB—uterus—uterine cancer	0.000496	0.00672	CbGeAlD
Acetylsalicylic acid—Hypoglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.000495	0.00818	CcSEcCtD
Acetylsalicylic acid—Hepatotoxicity—Etoposide—uterine cancer	0.000487	0.00804	CcSEcCtD
Acetylsalicylic acid—TP53—Podofilox—Etoposide—uterine cancer	0.000477	0.148	CbGdCrCtD
Acetylsalicylic acid—Asthma—Progesterone—uterine cancer	0.000461	0.00761	CcSEcCtD
Acetylsalicylic acid—EDNRA—female gonad—uterine cancer	0.000447	0.00606	CbGeAlD
Acetylsalicylic acid—IKBKB—female reproductive system—uterine cancer	0.000446	0.00604	CbGeAlD
Acetylsalicylic acid—EDNRA—vagina—uterine cancer	0.000444	0.00602	CbGeAlD
Acetylsalicylic acid—Hypokalaemia—Medroxyprogesterone Acetate—uterine cancer	0.00044	0.00726	CcSEcCtD
Acetylsalicylic acid—Kidney function abnormal—Epirubicin—uterine cancer	0.000436	0.0072	CcSEcCtD
Acetylsalicylic acid—TP53—lymph node—uterine cancer	0.00043	0.00583	CbGeAlD
Acetylsalicylic acid—Chest discomfort—Etoposide—uterine cancer	0.000425	0.00702	CcSEcCtD
Acetylsalicylic acid—NFKBIA—lymph node—uterine cancer	0.000423	0.00574	CbGeAlD
Acetylsalicylic acid—Influenza—Medroxyprogesterone Acetate—uterine cancer	0.000418	0.0069	CcSEcCtD
Acetylsalicylic acid—Asthma—Medroxyprogesterone Acetate—uterine cancer	0.000418	0.0069	CcSEcCtD
Acetylsalicylic acid—HSPA5—lymph node—uterine cancer	0.000415	0.00562	CbGeAlD
Acetylsalicylic acid—Drowsiness—Progesterone—uterine cancer	0.000411	0.00679	CcSEcCtD
Acetylsalicylic acid—IKBKB—female gonad—uterine cancer	0.000406	0.0055	CbGeAlD
Acetylsalicylic acid—Kidney function abnormal—Doxorubicin—uterine cancer	0.000404	0.00666	CcSEcCtD
Acetylsalicylic acid—IKBKB—vagina—uterine cancer	0.000403	0.00546	CbGeAlD
Acetylsalicylic acid—Ulcer—Etoposide—uterine cancer	0.000398	0.00656	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.000373	0.00615	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Progesterone—uterine cancer	0.000371	0.00612	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Progesterone—uterine cancer	0.000369	0.00609	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Podofilox—Etoposide—uterine cancer	0.000361	0.112	CbGdCrCtD
Acetylsalicylic acid—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.000357	0.0059	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—lymph node—uterine cancer	0.000353	0.00479	CbGeAlD
Acetylsalicylic acid—TP53—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.000347	0.108	CbGdCrCtD
Acetylsalicylic acid—Tinnitus—Progesterone—uterine cancer	0.000344	0.00568	CcSEcCtD
Acetylsalicylic acid—Eruption—Epirubicin—uterine cancer	0.000343	0.00566	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.000336	0.00555	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.000334	0.00552	CcSEcCtD
Acetylsalicylic acid—Eruption—Doxorubicin—uterine cancer	0.000317	0.00523	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.000312	0.00515	CcSEcCtD
Acetylsalicylic acid—Haematemesis—Epirubicin—uterine cancer	0.000303	0.00501	CcSEcCtD
Acetylsalicylic acid—TP53—Testosterone—Progesterone—uterine cancer	0.000302	0.0939	CbGdCrCtD
Acetylsalicylic acid—Anaemia—Progesterone—uterine cancer	0.000297	0.0049	CcSEcCtD
Acetylsalicylic acid—Angioedema—Progesterone—uterine cancer	0.000294	0.00485	CcSEcCtD
Acetylsalicylic acid—Vertigo—Progesterone—uterine cancer	0.000289	0.00477	CcSEcCtD
Acetylsalicylic acid—Syncope—Progesterone—uterine cancer	0.000288	0.00476	CcSEcCtD
Acetylsalicylic acid—EDNRA—lymph node—uterine cancer	0.000287	0.00389	CbGeAlD
Acetylsalicylic acid—Loss of consciousness—Progesterone—uterine cancer	0.000282	0.00466	CcSEcCtD
Acetylsalicylic acid—Haematemesis—Doxorubicin—uterine cancer	0.000281	0.00463	CcSEcCtD
Acetylsalicylic acid—Convulsion—Progesterone—uterine cancer	0.000278	0.0046	CcSEcCtD
Acetylsalicylic acid—Hypertension—Progesterone—uterine cancer	0.000277	0.00458	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Progesterone—uterine cancer	0.000274	0.00452	CcSEcCtD
Acetylsalicylic acid—Chest pain—Progesterone—uterine cancer	0.000274	0.00452	CcSEcCtD
Acetylsalicylic acid—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000269	0.00444	CcSEcCtD
Acetylsalicylic acid—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.000268	0.00442	CcSEcCtD
Acetylsalicylic acid—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.000266	0.00439	CcSEcCtD
Acetylsalicylic acid—Confusional state—Progesterone—uterine cancer	0.000264	0.00437	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Progesterone—uterine cancer	0.000262	0.00433	CcSEcCtD
Acetylsalicylic acid—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.000262	0.00432	CcSEcCtD
Acetylsalicylic acid—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.000261	0.00431	CcSEcCtD
Acetylsalicylic acid—IKBKB—lymph node—uterine cancer	0.000261	0.00353	CbGeAlD
Acetylsalicylic acid—Shock—Progesterone—uterine cancer	0.000258	0.00426	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Progesterone—uterine cancer	0.000256	0.00423	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.000256	0.00422	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Progesterone—uterine cancer	0.000254	0.00419	CcSEcCtD
Acetylsalicylic acid—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.000252	0.00416	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.000248	0.00409	CcSEcCtD
Acetylsalicylic acid—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.000248	0.00409	CcSEcCtD
Acetylsalicylic acid—TP53—Danazol—Progesterone—uterine cancer	0.000245	0.0762	CbGdCrCtD
Acetylsalicylic acid—PTGS2—myometrium—uterine cancer	0.000243	0.0033	CbGeAlD
Acetylsalicylic acid—Flushing—Dactinomycin—uterine cancer	0.000242	0.004	CcSEcCtD
Acetylsalicylic acid—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00024	0.00396	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000238	0.00392	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Progesterone—uterine cancer	0.000234	0.00386	CcSEcCtD
Acetylsalicylic acid—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000234	0.00386	CcSEcCtD
Acetylsalicylic acid—Somnolence—Progesterone—uterine cancer	0.000233	0.00385	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000233	0.00384	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000232	0.00383	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Progesterone—uterine cancer	0.000231	0.00381	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00023	0.00379	CcSEcCtD
Acetylsalicylic acid—CYP2C8—renal system—uterine cancer	0.000228	0.0031	CbGeAlD
Acetylsalicylic acid—Ulcer—Epirubicin—uterine cancer	0.000223	0.00368	CcSEcCtD
Acetylsalicylic acid—TP53—Norethindrone—Progesterone—uterine cancer	0.000221	0.0687	CbGdCrCtD
Acetylsalicylic acid—CYP2C8—endometrium—uterine cancer	0.000221	0.00299	CbGeAlD
Acetylsalicylic acid—Feeling abnormal—Progesterone—uterine cancer	0.000216	0.00357	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000212	0.0035	CcSEcCtD
Acetylsalicylic acid—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000211	0.00349	CcSEcCtD
Acetylsalicylic acid—Hepatocellular injury—Epirubicin—uterine cancer	0.000211	0.00348	CcSEcCtD
Acetylsalicylic acid—Anaemia—Dactinomycin—uterine cancer	0.00021	0.00347	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000209	0.00345	CcSEcCtD
Acetylsalicylic acid—Urticaria—Progesterone—uterine cancer	0.000208	0.00344	CcSEcCtD
Acetylsalicylic acid—Ulcer—Doxorubicin—uterine cancer	0.000206	0.0034	CcSEcCtD
Acetylsalicylic acid—Melaena—Epirubicin—uterine cancer	0.000206	0.0034	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Dactinomycin—uterine cancer	0.000203	0.00336	CcSEcCtD
Acetylsalicylic acid—PTGS1—epithelium—uterine cancer	0.0002	0.00271	CbGeAlD
Acetylsalicylic acid—PTGS1—uterine cervix—uterine cancer	0.000198	0.00268	CbGeAlD
Acetylsalicylic acid—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000196	0.00323	CcSEcCtD
Acetylsalicylic acid—Hepatocellular injury—Doxorubicin—uterine cancer	0.000195	0.00322	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Progesterone—uterine cancer	0.000193	0.00319	CcSEcCtD
Acetylsalicylic acid—Coma—Epirubicin—uterine cancer	0.000193	0.00318	CcSEcCtD
Acetylsalicylic acid—PTGS1—smooth muscle tissue—uterine cancer	0.000192	0.00261	CbGeAlD
Acetylsalicylic acid—PTGS2—epithelium—uterine cancer	0.000191	0.00259	CbGeAlD
Acetylsalicylic acid—Melaena—Doxorubicin—uterine cancer	0.00019	0.00314	CcSEcCtD
Acetylsalicylic acid—CYP2C19—vagina—uterine cancer	0.000189	0.00257	CbGeAlD
Acetylsalicylic acid—PTGS2—uterine cervix—uterine cancer	0.000189	0.00256	CbGeAlD
Acetylsalicylic acid—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000189	0.00312	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Epirubicin—uterine cancer	0.000188	0.0586	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Doxorubicin—Epirubicin—uterine cancer	0.000188	0.0586	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Idarubicin—Epirubicin—uterine cancer	0.000188	0.0586	CbGdCrCtD
Acetylsalicylic acid—Pruritus—Progesterone—uterine cancer	0.000186	0.00306	CcSEcCtD
Acetylsalicylic acid—PTGS1—renal system—uterine cancer	0.000185	0.00251	CbGeAlD
Acetylsalicylic acid—PTGS2—smooth muscle tissue—uterine cancer	0.000184	0.00249	CbGeAlD
Acetylsalicylic acid—CYP2C8—female reproductive system—uterine cancer	0.000183	0.00248	CbGeAlD
Acetylsalicylic acid—Thrombocytopenia—Dactinomycin—uterine cancer	0.000181	0.003	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Progesterone—uterine cancer	0.000179	0.00296	CcSEcCtD
Acetylsalicylic acid—PTGS1—endometrium—uterine cancer	0.000179	0.00243	CbGeAlD
Acetylsalicylic acid—Coma—Doxorubicin—uterine cancer	0.000178	0.00294	CcSEcCtD
Acetylsalicylic acid—PTGS2—renal system—uterine cancer	0.000177	0.0024	CbGeAlD
Acetylsalicylic acid—Diabetes mellitus—Epirubicin—uterine cancer	0.000176	0.0029	CcSEcCtD
Acetylsalicylic acid—TP53—Levonorgestrel—Progesterone—uterine cancer	0.000176	0.0547	CbGdCrCtD
Acetylsalicylic acid—Flushing—Etoposide—uterine cancer	0.000175	0.00289	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000175	0.00289	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Epirubicin—Doxorubicin—uterine cancer	0.000174	0.0542	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Idarubicin—Doxorubicin—uterine cancer	0.000174	0.0542	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Doxorubicin—uterine cancer	0.000174	0.0542	CbGdCrCtD
Acetylsalicylic acid—Dizziness—Progesterone—uterine cancer	0.000173	0.00286	CcSEcCtD
Acetylsalicylic acid—PTGS1—mammalian vulva—uterine cancer	0.000173	0.00235	CbGeAlD
Acetylsalicylic acid—PTGS2—endometrium—uterine cancer	0.000171	0.00232	CbGeAlD
Acetylsalicylic acid—Vascular purpura—Epirubicin—uterine cancer	0.000171	0.00282	CcSEcCtD
Acetylsalicylic acid—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000168	0.00278	CcSEcCtD
Acetylsalicylic acid—Vomiting—Progesterone—uterine cancer	0.000167	0.00275	CcSEcCtD
Acetylsalicylic acid—CYP2C8—vagina—uterine cancer	0.000165	0.00224	CbGeAlD
Acetylsalicylic acid—Rash—Progesterone—uterine cancer	0.000165	0.00273	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Progesterone—uterine cancer	0.000165	0.00273	CcSEcCtD
Acetylsalicylic acid—PTGS1—uterus—uterine cancer	0.000165	0.00224	CbGeAlD
Acetylsalicylic acid—Diabetes mellitus—Doxorubicin—uterine cancer	0.000163	0.00269	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000163	0.00268	CcSEcCtD
Acetylsalicylic acid—CYP2C9—female reproductive system—uterine cancer	0.000162	0.0022	CbGeAlD
Acetylsalicylic acid—Renal impairment—Epirubicin—uterine cancer	0.000161	0.00265	CcSEcCtD
Acetylsalicylic acid—Purpura—Epirubicin—uterine cancer	0.000159	0.00262	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Doxorubicin—uterine cancer	0.000158	0.00261	CcSEcCtD
Acetylsalicylic acid—PTGS2—uterus—uterine cancer	0.000158	0.00214	CbGeAlD
Acetylsalicylic acid—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000157	0.00259	CcSEcCtD
Acetylsalicylic acid—Hypoglycaemia—Epirubicin—uterine cancer	0.000157	0.00259	CcSEcCtD
Acetylsalicylic acid—Nausea—Progesterone—uterine cancer	0.000156	0.00257	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000153	0.00253	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Dactinomycin—uterine cancer	0.000153	0.00252	CcSEcCtD
Acetylsalicylic acid—ALB—lymph node—uterine cancer	0.000152	0.00206	CbGeAlD
Acetylsalicylic acid—Anaemia—Etoposide—uterine cancer	0.000152	0.00251	CcSEcCtD
Acetylsalicylic acid—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000151	0.00249	CcSEcCtD
Acetylsalicylic acid—ABCB1—myometrium—uterine cancer	0.00015	0.00204	CbGeAlD
Acetylsalicylic acid—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00015	0.00247	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00015	0.00247	CcSEcCtD
Acetylsalicylic acid—Renal impairment—Doxorubicin—uterine cancer	0.000149	0.00246	CcSEcCtD
Acetylsalicylic acid—PTGS1—female reproductive system—uterine cancer	0.000148	0.00201	CbGeAlD
Acetylsalicylic acid—Vertigo—Etoposide—uterine cancer	0.000148	0.00244	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Etoposide—uterine cancer	0.000147	0.00243	CcSEcCtD
Acetylsalicylic acid—Purpura—Doxorubicin—uterine cancer	0.000147	0.00242	CcSEcCtD
Acetylsalicylic acid—Hypoglycaemia—Doxorubicin—uterine cancer	0.000145	0.00239	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Etoposide—uterine cancer	0.000144	0.00238	CcSEcCtD
Acetylsalicylic acid—Convulsion—Etoposide—uterine cancer	0.000142	0.00235	CcSEcCtD
Acetylsalicylic acid—Hypertension—Etoposide—uterine cancer	0.000142	0.00234	CcSEcCtD
Acetylsalicylic acid—PTGS2—female reproductive system—uterine cancer	0.000142	0.00192	CbGeAlD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000142	0.00234	CcSEcCtD
Acetylsalicylic acid—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000141	0.00233	CcSEcCtD
Acetylsalicylic acid—Chest pain—Etoposide—uterine cancer	0.00014	0.00231	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Epirubicin—uterine cancer	0.000139	0.0023	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Dactinomycin—uterine cancer	0.000137	0.00225	CcSEcCtD
Acetylsalicylic acid—Confusional state—Etoposide—uterine cancer	0.000135	0.00223	CcSEcCtD
Acetylsalicylic acid—PTGS1—female gonad—uterine cancer	0.000135	0.00183	CbGeAlD
Acetylsalicylic acid—Anaphylactic shock—Etoposide—uterine cancer	0.000134	0.00221	CcSEcCtD
Acetylsalicylic acid—PTGS1—vagina—uterine cancer	0.000134	0.00182	CbGeAlD
Acetylsalicylic acid—Influenza—Epirubicin—uterine cancer	0.000132	0.00218	CcSEcCtD
Acetylsalicylic acid—Asthma—Epirubicin—uterine cancer	0.000132	0.00218	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Etoposide—uterine cancer	0.000131	0.00217	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Etoposide—uterine cancer	0.000131	0.00216	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Etoposide—uterine cancer	0.00013	0.00214	CcSEcCtD
Acetylsalicylic acid—PTGS2—female gonad—uterine cancer	0.000129	0.00175	CbGeAlD
Acetylsalicylic acid—Hypokalaemia—Doxorubicin—uterine cancer	0.000129	0.00213	CcSEcCtD
Acetylsalicylic acid—PTGS2—vagina—uterine cancer	0.000128	0.00174	CbGeAlD
Acetylsalicylic acid—Diarrhoea—Dactinomycin—uterine cancer	0.000127	0.00209	CcSEcCtD
Acetylsalicylic acid—Asthma—Doxorubicin—uterine cancer	0.000122	0.00202	CcSEcCtD
Acetylsalicylic acid—Influenza—Doxorubicin—uterine cancer	0.000122	0.00202	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Etoposide—uterine cancer	0.00012	0.00197	CcSEcCtD
Acetylsalicylic acid—Somnolence—Etoposide—uterine cancer	0.000119	0.00197	CcSEcCtD
Acetylsalicylic acid—ABCB1—epithelium—uterine cancer	0.000118	0.0016	CbGeAlD
Acetylsalicylic acid—Drowsiness—Epirubicin—uterine cancer	0.000118	0.00195	CcSEcCtD
Acetylsalicylic acid—Vomiting—Dactinomycin—uterine cancer	0.000118	0.00195	CcSEcCtD
Acetylsalicylic acid—ABCB1—uterine cervix—uterine cancer	0.000117	0.00159	CbGeAlD
Acetylsalicylic acid—Rash—Dactinomycin—uterine cancer	0.000117	0.00193	CcSEcCtD
Acetylsalicylic acid—Sweating—Epirubicin—uterine cancer	0.000113	0.00187	CcSEcCtD
Acetylsalicylic acid—ABCB1—decidua—uterine cancer	0.000111	0.00151	CbGeAlD
Acetylsalicylic acid—Feeling abnormal—Etoposide—uterine cancer	0.000111	0.00182	CcSEcCtD
Acetylsalicylic acid—Nausea—Dactinomycin—uterine cancer	0.00011	0.00182	CcSEcCtD
Acetylsalicylic acid—ABCB1—renal system—uterine cancer	0.000109	0.00148	CbGeAlD
Acetylsalicylic acid—Drowsiness—Doxorubicin—uterine cancer	0.000109	0.0018	CcSEcCtD
Acetylsalicylic acid—Urticaria—Etoposide—uterine cancer	0.000107	0.00176	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Epirubicin—uterine cancer	0.000106	0.00176	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Epirubicin—uterine cancer	0.000106	0.00175	CcSEcCtD
Acetylsalicylic acid—ABCB1—endometrium—uterine cancer	0.000106	0.00143	CbGeAlD
Acetylsalicylic acid—Sweating—Doxorubicin—uterine cancer	0.000105	0.00173	CcSEcCtD
Acetylsalicylic acid—ABCB1—mammalian vulva—uterine cancer	0.000102	0.00139	CbGeAlD
Acetylsalicylic acid—Hypersensitivity—Etoposide—uterine cancer	9.88e-05	0.00163	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Epirubicin—uterine cancer	9.87e-05	0.00163	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Doxorubicin—uterine cancer	9.84e-05	0.00162	CcSEcCtD
Acetylsalicylic acid—Flushing—Epirubicin—uterine cancer	9.82e-05	0.00162	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Doxorubicin—uterine cancer	9.79e-05	0.00162	CcSEcCtD
Acetylsalicylic acid—ABCB1—uterus—uterine cancer	9.75e-05	0.00132	CbGeAlD
Acetylsalicylic acid—Pruritus—Etoposide—uterine cancer	9.49e-05	0.00157	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Etoposide—uterine cancer	9.18e-05	0.00152	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Doxorubicin—uterine cancer	9.13e-05	0.00151	CcSEcCtD
Acetylsalicylic acid—Flushing—Doxorubicin—uterine cancer	9.09e-05	0.0015	CcSEcCtD
Acetylsalicylic acid—Dizziness—Etoposide—uterine cancer	8.87e-05	0.00146	CcSEcCtD
Acetylsalicylic acid—ABCB1—female reproductive system—uterine cancer	8.77e-05	0.00119	CbGeAlD
Acetylsalicylic acid—PTGS1—lymph node—uterine cancer	8.67e-05	0.00118	CbGeAlD
Acetylsalicylic acid—Vomiting—Etoposide—uterine cancer	8.53e-05	0.00141	CcSEcCtD
Acetylsalicylic acid—Anaemia—Epirubicin—uterine cancer	8.52e-05	0.00141	CcSEcCtD
Acetylsalicylic acid—Agitation—Epirubicin—uterine cancer	8.47e-05	0.0014	CcSEcCtD
Acetylsalicylic acid—Rash—Etoposide—uterine cancer	8.46e-05	0.0014	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Etoposide—uterine cancer	8.45e-05	0.0014	CcSEcCtD
Acetylsalicylic acid—PTGS2—lymph node—uterine cancer	8.29e-05	0.00112	CbGeAlD
Acetylsalicylic acid—Vertigo—Epirubicin—uterine cancer	8.28e-05	0.00137	CcSEcCtD
Acetylsalicylic acid—Syncope—Epirubicin—uterine cancer	8.26e-05	0.00136	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Epirubicin—uterine cancer	8.25e-05	0.00136	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Epirubicin—uterine cancer	8.1e-05	0.00134	CcSEcCtD
Acetylsalicylic acid—Convulsion—Epirubicin—uterine cancer	7.98e-05	0.00132	CcSEcCtD
Acetylsalicylic acid—ABCB1—female gonad—uterine cancer	7.98e-05	0.00108	CbGeAlD
Acetylsalicylic acid—Nausea—Etoposide—uterine cancer	7.97e-05	0.00132	CcSEcCtD
Acetylsalicylic acid—Hypertension—Epirubicin—uterine cancer	7.95e-05	0.00131	CcSEcCtD
Acetylsalicylic acid—ABCB1—vagina—uterine cancer	7.93e-05	0.00107	CbGeAlD
Acetylsalicylic acid—Anaemia—Doxorubicin—uterine cancer	7.88e-05	0.0013	CcSEcCtD
Acetylsalicylic acid—Chest pain—Epirubicin—uterine cancer	7.84e-05	0.00129	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Epirubicin—uterine cancer	7.84e-05	0.00129	CcSEcCtD
Acetylsalicylic acid—Agitation—Doxorubicin—uterine cancer	7.83e-05	0.00129	CcSEcCtD
Acetylsalicylic acid—Vertigo—Doxorubicin—uterine cancer	7.66e-05	0.00126	CcSEcCtD
Acetylsalicylic acid—Syncope—Doxorubicin—uterine cancer	7.65e-05	0.00126	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Doxorubicin—uterine cancer	7.63e-05	0.00126	CcSEcCtD
Acetylsalicylic acid—Confusional state—Epirubicin—uterine cancer	7.58e-05	0.00125	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Epirubicin—uterine cancer	7.52e-05	0.00124	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Doxorubicin—uterine cancer	7.49e-05	0.00124	CcSEcCtD
Acetylsalicylic acid—Shock—Epirubicin—uterine cancer	7.4e-05	0.00122	CcSEcCtD
Acetylsalicylic acid—Convulsion—Doxorubicin—uterine cancer	7.39e-05	0.00122	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Epirubicin—uterine cancer	7.36e-05	0.00122	CcSEcCtD
Acetylsalicylic acid—Hypertension—Doxorubicin—uterine cancer	7.36e-05	0.00122	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Epirubicin—uterine cancer	7.34e-05	0.00121	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Epirubicin—uterine cancer	7.27e-05	0.0012	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Doxorubicin—uterine cancer	7.26e-05	0.0012	CcSEcCtD
Acetylsalicylic acid—Chest pain—Doxorubicin—uterine cancer	7.26e-05	0.0012	CcSEcCtD
Acetylsalicylic acid—Confusional state—Doxorubicin—uterine cancer	7.02e-05	0.00116	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Doxorubicin—uterine cancer	6.96e-05	0.00115	CcSEcCtD
Acetylsalicylic acid—Shock—Doxorubicin—uterine cancer	6.85e-05	0.00113	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Doxorubicin—uterine cancer	6.81e-05	0.00112	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Doxorubicin—uterine cancer	6.79e-05	0.00112	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Doxorubicin—uterine cancer	6.73e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Epirubicin—uterine cancer	6.7e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—Somnolence—Epirubicin—uterine cancer	6.68e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Epirubicin—uterine cancer	6.62e-05	0.00109	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Doxorubicin—uterine cancer	6.2e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Epirubicin—uterine cancer	6.2e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Somnolence—Doxorubicin—uterine cancer	6.19e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Doxorubicin—uterine cancer	6.12e-05	0.00101	CcSEcCtD
Acetylsalicylic acid—Urticaria—Epirubicin—uterine cancer	5.97e-05	0.000986	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Doxorubicin—uterine cancer	5.73e-05	0.000947	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Epirubicin—uterine cancer	5.54e-05	0.000915	CcSEcCtD
Acetylsalicylic acid—Urticaria—Doxorubicin—uterine cancer	5.53e-05	0.000913	CcSEcCtD
Acetylsalicylic acid—Pruritus—Epirubicin—uterine cancer	5.32e-05	0.000878	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Epirubicin—uterine cancer	5.14e-05	0.000849	CcSEcCtD
Acetylsalicylic acid—ABCB1—lymph node—uterine cancer	5.13e-05	0.000695	CbGeAlD
Acetylsalicylic acid—Hypersensitivity—Doxorubicin—uterine cancer	5.13e-05	0.000846	CcSEcCtD
Acetylsalicylic acid—Dizziness—Epirubicin—uterine cancer	4.97e-05	0.000821	CcSEcCtD
Acetylsalicylic acid—Pruritus—Doxorubicin—uterine cancer	4.92e-05	0.000813	CcSEcCtD
Acetylsalicylic acid—Vomiting—Epirubicin—uterine cancer	4.78e-05	0.000789	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Doxorubicin—uterine cancer	4.76e-05	0.000786	CcSEcCtD
Acetylsalicylic acid—Rash—Epirubicin—uterine cancer	4.74e-05	0.000783	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Epirubicin—uterine cancer	4.74e-05	0.000782	CcSEcCtD
Acetylsalicylic acid—Dizziness—Doxorubicin—uterine cancer	4.6e-05	0.00076	CcSEcCtD
Acetylsalicylic acid—Nausea—Epirubicin—uterine cancer	4.47e-05	0.000737	CcSEcCtD
Acetylsalicylic acid—Vomiting—Doxorubicin—uterine cancer	4.42e-05	0.00073	CcSEcCtD
Acetylsalicylic acid—Rash—Doxorubicin—uterine cancer	4.39e-05	0.000724	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Doxorubicin—uterine cancer	4.38e-05	0.000724	CcSEcCtD
Acetylsalicylic acid—Nausea—Doxorubicin—uterine cancer	4.13e-05	0.000682	CcSEcCtD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—PIK3CA—uterine cancer	6.91e-06	6.94e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—ERBB2—uterine cancer	6.89e-06	6.92e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—HRAS—uterine cancer	6.84e-06	6.87e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—KRAS—uterine cancer	6.83e-06	6.86e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—KRAS—uterine cancer	6.83e-06	6.86e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—ERBB2—uterine cancer	6.81e-06	6.84e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—FBXW7—uterine cancer	6.67e-06	6.7e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—PTEN—uterine cancer	6.66e-06	6.69e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CYP11A1—uterine cancer	6.64e-06	6.66e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—VEGFA—uterine cancer	6.63e-06	6.66e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—AKR1C1—uterine cancer	6.62e-06	6.65e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—EP300—uterine cancer	6.62e-06	6.64e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—AKR1C1—uterine cancer	6.59e-06	6.61e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—NRAS—uterine cancer	6.55e-06	6.58e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CXCL8—uterine cancer	6.54e-06	6.56e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CXCL8—uterine cancer	6.46e-06	6.49e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—PIK3CA—uterine cancer	6.41e-06	6.44e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CDKN1B—uterine cancer	6.38e-06	6.41e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	6.33e-06	6.35e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—POLD1—uterine cancer	6.32e-06	6.35e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CDKN1B—uterine cancer	6.31e-06	6.33e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—PIK3CA—uterine cancer	6.27e-06	6.3e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—PIK3CA—uterine cancer	6.27e-06	6.3e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—AKR1C3—uterine cancer	6.27e-06	6.29e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—STK11—uterine cancer	6.25e-06	6.28e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—KRAS—uterine cancer	6.24e-06	6.26e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—PIK3CA—uterine cancer	6.19e-06	6.22e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—NRAS—uterine cancer	6.19e-06	6.22e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—POLD1—uterine cancer	6.17e-06	6.19e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—ERBB2—uterine cancer	6.16e-06	6.19e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—ERBB2—uterine cancer	6.16e-06	6.19e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—STK11—uterine cancer	6.15e-06	6.18e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CYP19A1—uterine cancer	6.15e-06	6.18e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—AKT1—uterine cancer	6.04e-06	6.07e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CTNNB1—uterine cancer	6.03e-06	6.05e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	5.97e-06	6e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CTNNB1—uterine cancer	5.96e-06	5.98e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—NRAS—uterine cancer	5.94e-06	5.97e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—HRAS—uterine cancer	5.93e-06	5.96e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—AKR1C1—uterine cancer	5.91e-06	5.94e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—RRM2—uterine cancer	5.9e-06	5.93e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—PTEN—uterine cancer	5.88e-06	5.9e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—RRM2—uterine cancer	5.87e-06	5.89e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SOCS3—uterine cancer	5.85e-06	5.88e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CXCL8—uterine cancer	5.84e-06	5.87e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CXCL8—uterine cancer	5.84e-06	5.87e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—PTEN—uterine cancer	5.81e-06	5.83e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—HRAS—uterine cancer	5.8e-06	5.83e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—HRAS—uterine cancer	5.8e-06	5.83e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.77e-06	5.8e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—AKR1C1—uterine cancer	5.77e-06	5.79e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—POLD1—uterine cancer	5.76e-06	5.79e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—PIK3CA—uterine cancer	5.73e-06	5.76e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—DCN—uterine cancer	5.73e-06	5.75e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CDKN1B—uterine cancer	5.71e-06	5.73e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CDKN1B—uterine cancer	5.71e-06	5.73e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—DCN—uterine cancer	5.7e-06	5.72e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—AKT1—uterine cancer	5.64e-06	5.67e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—KRAS—uterine cancer	5.64e-06	5.66e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CDH1—uterine cancer	5.62e-06	5.64e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—EP300—uterine cancer	5.6e-06	5.63e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CDKN2B—uterine cancer	5.6e-06	5.63e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	5.57e-06	5.6e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—EP300—uterine cancer	5.54e-06	5.56e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.51e-06	5.53e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	5.49e-06	5.51e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IGF1R—uterine cancer	5.44e-06	5.46e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP11A1—uterine cancer	5.4e-06	5.42e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AKR1C1—uterine cancer	5.39e-06	5.41e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CTNNB1—uterine cancer	5.39e-06	5.41e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CTNNB1—uterine cancer	5.39e-06	5.41e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP11A1—uterine cancer	5.37e-06	5.39e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—KRAS—uterine cancer	5.33e-06	5.35e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	5.31e-06	5.33e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—VEGFA—uterine cancer	5.31e-06	5.33e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HRAS—uterine cancer	5.3e-06	5.33e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—RRM2—uterine cancer	5.27e-06	5.29e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PTEN—uterine cancer	5.25e-06	5.27e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PTEN—uterine cancer	5.25e-06	5.27e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—VEGFA—uterine cancer	5.25e-06	5.27e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—NRAS—uterine cancer	5.24e-06	5.26e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—AKT1—uterine cancer	5.24e-06	5.26e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CDKN2B—uterine cancer	5.23e-06	5.25e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—NRAS—uterine cancer	5.18e-06	5.2e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—PIK3CA—uterine cancer	5.18e-06	5.2e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—RRM2—uterine cancer	5.14e-06	5.16e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—AKT1—uterine cancer	5.13e-06	5.15e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—AKT1—uterine cancer	5.13e-06	5.15e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—DCN—uterine cancer	5.12e-06	5.14e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—KRAS—uterine cancer	5.12e-06	5.14e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SMAD3—uterine cancer	5.12e-06	5.14e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—AKR1C3—uterine cancer	5.1e-06	5.12e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—AKR1C3—uterine cancer	5.07e-06	5.09e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—AKT1—uterine cancer	5.06e-06	5.08e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—EP300—uterine cancer	5.01e-06	5.03e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—EP300—uterine cancer	5.01e-06	5.03e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TP53—uterine cancer	5.01e-06	5.03e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—DCN—uterine cancer	4.99e-06	5.01e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—PIK3CA—uterine cancer	4.89e-06	4.91e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—STK11—uterine cancer	4.88e-06	4.9e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CYP19A1—uterine cancer	4.88e-06	4.9e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FGFR2—uterine cancer	4.88e-06	4.9e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP11A1—uterine cancer	4.82e-06	4.84e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—RRM2—uterine cancer	4.81e-06	4.82e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—HRAS—uterine cancer	4.79e-06	4.81e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SMAD3—uterine cancer	4.77e-06	4.79e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—VEGFA—uterine cancer	4.75e-06	4.76e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—VEGFA—uterine cancer	4.75e-06	4.76e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ERBB2—uterine cancer	4.74e-06	4.76e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP11A1—uterine cancer	4.7e-06	4.72e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—PIK3CA—uterine cancer	4.7e-06	4.72e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—NRAS—uterine cancer	4.69e-06	4.71e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—NRAS—uterine cancer	4.69e-06	4.71e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—AKT1—uterine cancer	4.68e-06	4.7e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—DCN—uterine cancer	4.66e-06	4.68e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—MTHFR—uterine cancer	4.62e-06	4.64e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.58e-06	4.6e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	4.55e-06	4.57e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—AKR1C3—uterine cancer	4.55e-06	4.57e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—FGFR2—uterine cancer	4.55e-06	4.57e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—HRAS—uterine cancer	4.53e-06	4.55e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—KRAS—uterine cancer	4.51e-06	4.53e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	4.48e-06	4.5e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—KRAS—uterine cancer	4.46e-06	4.48e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—AKR1C3—uterine cancer	4.44e-06	4.46e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP11A1—uterine cancer	4.4e-06	4.41e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CDKN1B—uterine cancer	4.39e-06	4.41e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MTHFR—uterine cancer	4.38e-06	4.4e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.37e-06	4.39e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HRAS—uterine cancer	4.35e-06	4.37e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—AKT1—uterine cancer	4.23e-06	4.25e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ESR1—uterine cancer	4.17e-06	4.19e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AKR1C3—uterine cancer	4.15e-06	4.17e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CTNNB1—uterine cancer	4.15e-06	4.16e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—PIK3CA—uterine cancer	4.15e-06	4.16e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—PIK3CA—uterine cancer	4.1e-06	4.11e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.07e-06	4.09e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PTEN—uterine cancer	4.04e-06	4.06e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—KRAS—uterine cancer	4.03e-06	4.05e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—KRAS—uterine cancer	4.03e-06	4.05e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TP53—uterine cancer	4.01e-06	4.03e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—AKT1—uterine cancer	4e-06	4.01e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—STK11—uterine cancer	3.97e-06	3.99e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP19A1—uterine cancer	3.97e-06	3.99e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—STK11—uterine cancer	3.95e-06	3.97e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP19A1—uterine cancer	3.95e-06	3.97e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—EP300—uterine cancer	3.88e-06	3.9e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—EP300—uterine cancer	3.85e-06	3.87e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—AKT1—uterine cancer	3.84e-06	3.86e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HRAS—uterine cancer	3.84e-06	3.85e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HRAS—uterine cancer	3.79e-06	3.81e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.73e-06	3.74e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.71e-06	3.72e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PIK3CA—uterine cancer	3.71e-06	3.72e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PIK3CA—uterine cancer	3.71e-06	3.72e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—VEGFA—uterine cancer	3.68e-06	3.69e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCL2—uterine cancer	3.68e-06	3.69e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—MTHFR—uterine cancer	3.67e-06	3.68e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—NRAS—uterine cancer	3.63e-06	3.65e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—NRAS—uterine cancer	3.61e-06	3.62e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—uterine cancer	3.59e-06	3.6e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—uterine cancer	3.59e-06	3.6e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.56e-06	3.57e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—STK11—uterine cancer	3.55e-06	3.56e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP19A1—uterine cancer	3.55e-06	3.56e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.54e-06	3.55e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—STK11—uterine cancer	3.46e-06	3.48e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP19A1—uterine cancer	3.46e-06	3.48e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HRAS—uterine cancer	3.43e-06	3.44e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HRAS—uterine cancer	3.43e-06	3.44e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—AKT1—uterine cancer	3.39e-06	3.4e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—AKT1—uterine cancer	3.35e-06	3.36e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.33e-06	3.34e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—STK11—uterine cancer	3.23e-06	3.25e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP19A1—uterine cancer	3.23e-06	3.25e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.23e-06	3.25e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.17e-06	3.19e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—KRAS—uterine cancer	3.13e-06	3.14e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—KRAS—uterine cancer	3.1e-06	3.12e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ERBB2—uterine cancer	3.06e-06	3.08e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.04e-06	3.05e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—AKT1—uterine cancer	3.03e-06	3.04e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—AKT1—uterine cancer	3.03e-06	3.04e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—MTHFR—uterine cancer	2.99e-06	3e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—MTHFR—uterine cancer	2.97e-06	2.98e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CXCL8—uterine cancer	2.91e-06	2.92e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.89e-06	2.91e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—PIK3CA—uterine cancer	2.87e-06	2.89e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ERBB2—uterine cancer	2.86e-06	2.87e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PIK3CA—uterine cancer	2.85e-06	2.86e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CDKN1B—uterine cancer	2.84e-06	2.85e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—uterine cancer	2.78e-06	2.79e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CTNNB1—uterine cancer	2.68e-06	2.69e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—MTHFR—uterine cancer	2.66e-06	2.68e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—HRAS—uterine cancer	2.66e-06	2.67e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CDKN1B—uterine cancer	2.65e-06	2.66e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HRAS—uterine cancer	2.64e-06	2.65e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.63e-06	2.64e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.62e-06	2.63e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTEN—uterine cancer	2.61e-06	2.62e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—MTHFR—uterine cancer	2.6e-06	2.61e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTEN—uterine cancer	2.57e-06	2.58e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CTNNB1—uterine cancer	2.5e-06	2.51e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EP300—uterine cancer	2.49e-06	2.5e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—EP300—uterine cancer	2.45e-06	2.46e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PTEN—uterine cancer	2.44e-06	2.45e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—MTHFR—uterine cancer	2.43e-06	2.44e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VEGFA—uterine cancer	2.36e-06	2.37e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.35e-06	2.36e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—AKT1—uterine cancer	2.35e-06	2.36e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NRAS—uterine cancer	2.33e-06	2.34e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—AKT1—uterine cancer	2.33e-06	2.34e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EP300—uterine cancer	2.32e-06	2.33e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NRAS—uterine cancer	2.17e-06	2.18e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.14e-06	2.15e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PTEN—uterine cancer	2.04e-06	2.05e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KRAS—uterine cancer	2.01e-06	2.01e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—EP300—uterine cancer	1.95e-06	1.95e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KRAS—uterine cancer	1.87e-06	1.88e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CA—uterine cancer	1.84e-06	1.85e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CA—uterine cancer	1.81e-06	1.82e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—uterine cancer	1.78e-06	1.79e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3CA—uterine cancer	1.72e-06	1.73e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HRAS—uterine cancer	1.71e-06	1.71e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTEN—uterine cancer	1.66e-06	1.67e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTEN—uterine cancer	1.65e-06	1.66e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HRAS—uterine cancer	1.59e-06	1.6e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—EP300—uterine cancer	1.58e-06	1.59e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—EP300—uterine cancer	1.57e-06	1.58e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—AKT1—uterine cancer	1.51e-06	1.51e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTEN—uterine cancer	1.48e-06	1.49e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—AKT1—uterine cancer	1.48e-06	1.49e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTEN—uterine cancer	1.45e-06	1.45e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CA—uterine cancer	1.44e-06	1.45e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—EP300—uterine cancer	1.41e-06	1.42e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—AKT1—uterine cancer	1.4e-06	1.41e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—EP300—uterine cancer	1.38e-06	1.39e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTEN—uterine cancer	1.35e-06	1.36e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—EP300—uterine cancer	1.29e-06	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—AKT1—uterine cancer	1.18e-06	1.18e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CA—uterine cancer	1.17e-06	1.18e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CA—uterine cancer	1.17e-06	1.17e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.05e-06	1.05e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CA—uterine cancer	1.02e-06	1.02e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—AKT1—uterine cancer	9.57e-07	9.61e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CA—uterine cancer	9.54e-07	9.57e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—AKT1—uterine cancer	9.52e-07	9.56e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—AKT1—uterine cancer	8.54e-07	8.58e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—AKT1—uterine cancer	8.34e-07	8.37e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AKT1—uterine cancer	7.79e-07	7.82e-06	CbGpPWpGaD
